FOCOSI, DANIELE Statistiche
FOCOSI, DANIELE
Rise of the BQ.1.1.37 SARS-CoV-2 Sublineage, Italy
2023-01-01 Focosi, Daniele; Spezia, Pietro Giorgio; Capria, Anna-Lisa; Gueli, Federico; Mcconnell, Scott; Novazzi, Federica; Pistello, Mauro
SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses
2023-01-01 Mazzetti, P.; Spezia, P. G.; Capria, A. -L.; Freer, G.; Sidoti, M.; Costarelli, S.; Cara, A.; Rosellini, A.; Frateschi, S.; Moscato, G.; Franconi, I.; Curcio, M.; Vatteroni, M. L.; Lai, M.; Quaranta, P.; Focosi, D.; Sani, S.; Pistello, M.
Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19
2022-01-01 Stincarelli, Maria Alfreda; Baj, Andreina; Guidotti, Bernardo; Spezia, Pietro Giorgio; Novazzi, Federica; Lucenteforte, Ersilia; Tillati, Silvia; Focosi, Daniele; Maggi, Fabrizio; Giannecchini, Simone
Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall
2022-01-01 Tuccori, Marco; Convertino, Irma; Ferraro, Sara; Cappello, Emiliano; Valdiserra, Giulia; de Luca, Giulia; Franchini, Massimo; Focosi, Daniele
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future
2021-01-01 Tuccori, M.; Convertino, I.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Fini, E.; Focosi, D.
Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer
2021-01-01 Focosi, D.; Rosellini, A.; Spezia, P. G.; Macera, L.; Lanza, M.; Paolicchi, A.; Biagini, D.; Baj, A.; Pistello, M.; Maggi, F.
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs
2021-01-01 Ferraro, S.; Tuccori, M.; Convertino, I.; Valdiserra, G.; Cappello, E.; Maggi, F.; Blandizzi, C.; Focosi, D.
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin
2021-01-01 Focosi, D.; Genoni, A.; Lucenteforte, E.; Tillati, S.; Tamborini, A.; Spezia, P. G.; Azzi, L.; Baj, A.; Maggi, F.
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
2020-01-01 Tuccori, M.; Ferraro, S.; Convertino, I.; Cappello, E.; Valdiserra, G.; Blandizzi, C.; Maggi, F.; Focosi, D.
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients
2020-01-01 Convertino, I.; Tuccori, M.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Focosi, D.; Blandizzi, C.
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
2020-01-01 Tuccori, M.; Convertino, I.; Ferraro, S.; Cappello, E.; Valdiserra, G.; Focosi, D.; Blandizzi, C.
Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation
2018-01-01 Albert, Eliseo; Torres, Ignacio; Talaya, Alberto; Giménez, Estela; Piñana, José Luis; Hernández-Boluda, Juan Carlos; Focosi, Daniele; Macera, Lisa; Maggi, Fabrizio; Solano, Carlos; Navarro, David
The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients
2018-01-01 Albert, EUGENIO HERMANN; Solano, C.; Giménez, E.; Focosi, D.; Pérez, A.; Macera, L.; Piñana, J. L.; Boluda, J. C. H.; Maggi, F.; Navarro, D.
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients
2017-01-01 Albert, Eliseo; Solano, Carlos; Pascual, Tania; Torres, Ignacio; Macera, Lisa; Focosi, Daniele; Maggi, Fabrizio; Giménez, Estela; Amat, Paula; Navarro, David
Kinetics of Torquetenovirus viremia in patients receiving solid organ transplantations
2017-01-01 Maggi, F.; Statzu, M.; Bianco, G.; Costa, C.; Focosi, D.; Macera, L.; Pistello, M.; Cavallo, R.; Antonelli, G.
Cyclovirus Vietnam DNA in immunodeficient patients
2016-01-01 Macera, Lisa; Focosi, Daniele; Vatteroni, Maria Linda; Manzin, Aldo; Antonelli, Guido; Pistello, Mauro; Maggi, Fabrizio
Effect of induced pluripotent stem cell technology in blood banking
2016-01-01 Focosi, Daniele; Pistello, Mauro
Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties
2016-01-01 Quaranta, Paola; Focosi, Daniele; DI IESU, Marilena; Cursi, Chiara; Zucca, Alessandra; Curcio, Michele; Lapi, Simone; Boldrini, Linda; Stampacchia, Giulia; Paolicchi, Aldo; Scatena, Fabrizio; Freer, Giulia; Pistello, Mauro
Torquetenovirus: the human virome from bench to bedside
2016-01-01 Focosi, Daniele; Antonelli, G.; Pistello, Mauro; Maggi, Fabrizio
Virome: the new Pandora’s box
2016-01-01 Maggi, F.; Macera, L.; Focosi, D.; Antonelli, G.; Pistello, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Rise of the BQ.1.1.37 SARS-CoV-2 Sublineage, Italy | 1-gen-2023 | Focosi, Daniele; Spezia, Pietro Giorgio; Capria, Anna-Lisa; Gueli, Federico; Mcconnell, Scott; Novazzi, Federica; Pistello, Mauro | |
| SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses | 1-gen-2023 | Mazzetti, P.; Spezia, P. G.; Capria, A. -L.; Freer, G.; Sidoti, M.; Costarelli, S.; Cara, A.; Rosellini, A.; Frateschi, S.; Moscato, G.; Franconi, I.; Curcio, M.; Vatteroni, M. L.; Lai, M.; Quaranta, P.; Focosi, D.; Sani, S.; Pistello, M. | |
| Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19 | 1-gen-2022 | Stincarelli, Maria Alfreda; Baj, Andreina; Guidotti, Bernardo; Spezia, Pietro Giorgio; Novazzi, Federica; Lucenteforte, Ersilia; Tillati, Silvia; Focosi, Daniele; Maggi, Fabrizio; Giannecchini, Simone | |
| Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall | 1-gen-2022 | Tuccori, Marco; Convertino, Irma; Ferraro, Sara; Cappello, Emiliano; Valdiserra, Giulia; de Luca, Giulia; Franchini, Massimo; Focosi, Daniele | |
| An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future | 1-gen-2021 | Tuccori, M.; Convertino, I.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Fini, E.; Focosi, D. | |
| Lack of neutralizing activity in nonconvalescent sera, regardless of ABO blood group and anti-A isoagglutinin titer | 1-gen-2021 | Focosi, D.; Rosellini, A.; Spezia, P. G.; Macera, L.; Lanza, M.; Paolicchi, A.; Biagini, D.; Baj, A.; Pistello, M.; Maggi, F. | |
| Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs | 1-gen-2021 | Ferraro, S.; Tuccori, M.; Convertino, I.; Valdiserra, G.; Cappello, E.; Maggi, F.; Blandizzi, C.; Focosi, D. | |
| Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin | 1-gen-2021 | Focosi, D.; Genoni, A.; Lucenteforte, E.; Tillati, S.; Tamborini, A.; Spezia, P. G.; Azzi, L.; Baj, A.; Maggi, F. | |
| Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline | 1-gen-2020 | Tuccori, M.; Ferraro, S.; Convertino, I.; Cappello, E.; Valdiserra, G.; Blandizzi, C.; Maggi, F.; Focosi, D. | |
| Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients | 1-gen-2020 | Convertino, I.; Tuccori, M.; Ferraro, S.; Valdiserra, G.; Cappello, E.; Focosi, D.; Blandizzi, C. | |
| The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance | 1-gen-2020 | Tuccori, M.; Convertino, I.; Ferraro, S.; Cappello, E.; Valdiserra, G.; Focosi, D.; Blandizzi, C. | |
| Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation | 1-gen-2018 | Albert, Eliseo; Torres, Ignacio; Talaya, Alberto; Giménez, Estela; Piñana, José Luis; Hernández-Boluda, Juan Carlos; Focosi, Daniele; Macera, Lisa; Maggi, Fabrizio; Solano, Carlos; Navarro, David | |
| The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients | 1-gen-2018 | Albert, EUGENIO HERMANN; Solano, C.; Giménez, E.; Focosi, D.; Pérez, A.; Macera, L.; Piñana, J. L.; Boluda, J. C. H.; Maggi, F.; Navarro, D. | |
| Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients | 1-gen-2017 | Albert, Eliseo; Solano, Carlos; Pascual, Tania; Torres, Ignacio; Macera, Lisa; Focosi, Daniele; Maggi, Fabrizio; Giménez, Estela; Amat, Paula; Navarro, David | |
| Kinetics of Torquetenovirus viremia in patients receiving solid organ transplantations | 1-gen-2017 | Maggi, F.; Statzu, M.; Bianco, G.; Costa, C.; Focosi, D.; Macera, L.; Pistello, M.; Cavallo, R.; Antonelli, G. | |
| Cyclovirus Vietnam DNA in immunodeficient patients | 1-gen-2016 | Macera, Lisa; Focosi, Daniele; Vatteroni, Maria Linda; Manzin, Aldo; Antonelli, Guido; Pistello, Mauro; Maggi, Fabrizio | |
| Effect of induced pluripotent stem cell technology in blood banking | 1-gen-2016 | Focosi, Daniele; Pistello, Mauro | |
| Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties | 1-gen-2016 | Quaranta, Paola; Focosi, Daniele; DI IESU, Marilena; Cursi, Chiara; Zucca, Alessandra; Curcio, Michele; Lapi, Simone; Boldrini, Linda; Stampacchia, Giulia; Paolicchi, Aldo; Scatena, Fabrizio; Freer, Giulia; Pistello, Mauro | |
| Torquetenovirus: the human virome from bench to bedside | 1-gen-2016 | Focosi, Daniele; Antonelli, G.; Pistello, Mauro; Maggi, Fabrizio | |
| Virome: the new Pandora’s box | 1-gen-2016 | Maggi, F.; Macera, L.; Focosi, D.; Antonelli, G.; Pistello, M. |